4/A//SEC Filing
DIXON WENDY L 4/A
Accession 0001415889-22-007101
CIK 0001701541other
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 4:07 PM ET
Size
5.5 KB
Accession
0001415889-22-007101
Insider Transaction Report
Form 4/AAmended
DIXON WENDY L
Director
Transactions
- Award
Common Stock
2022-06-17$2.03/sh+4,946$10,040→ 4,946 total
Footnotes (2)
- [F1]These shares were issued in accordance with the Issuer's Third Amended and Restated Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for annual services as a non-employee director of the Issuer.
- [F2]The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on June 16, 2022.
Documents
Issuer
Black Diamond Therapeutics, Inc.
CIK 0001701541
Entity typeother
Related Parties
1- filerCIK 0001202283
Filing Metadata
- Form type
- 4/A
- Filed
- Jun 29, 8:00 PM ET
- Accepted
- Jun 30, 4:07 PM ET
- Size
- 5.5 KB